期刊文献+

支气管哮喘患者人群慢性肾脏病流行病学调查 被引量:4

Epidemiology investigation on chronic kidney disease among patients with bronchial asthma
原文传递
导出
摘要 目的了解支气管哮喘患者人群慢性肾脏病流行病学现状。方法选择≥14岁的支气管哮喘患者为研究对象进行问卷调查、体格检查和肾脏损伤及相关危险因素检测。根据相关疾病诊断标准对资料进行分析。结果郑州市14岁以上支气管哮喘患者人群蛋白尿、血尿和估算肾小球滤过率(eGFR)下降患病率为别为9.41%、10.37%和3.03%,均高于普通人群。CKD患病率高达17.38%,女性显著高于男性(21.47%比13.99%,x2=6.060,P=0.014);CKD1~5期患病率分别为8.61%、5.10%、3.03%、0.48%和0.16%。在哮喘分期中,急性发作期CKD患病率为24.42%,显著高于慢性持续期和临床缓解期(x2=12.445,P=0.002);急性发作期蛋白尿和eGFR下降患病率均高于其他两期(x2=19.619,P〈0.01和x2=9.305,P=0.010)。结论支气管哮喘人群具有较高的肾脏损伤发生率,尤其在急性发作期,应重视此人群。肾损害的评估。 Objective To study the prevalence of chronic kidney disease (CKD) among patients with bronchial asthma in Zhengzhou. Methods A total of 655 patients (older than 14 years) were interviewed and received physical, uria and blood examination. Bronchial asthma and CKD were diagnosed according to related definition. Results The prevalence of albuminuria, hematuria, reduced eGFR and CKD was 9.41%,10.37%, 3.03% and 17.386% respectively in the above special patients, which was higher than that of the general population. Women had higher prevalence of CKD than men (21.47% vs 13.99%, x2=6.060, P=0.014). Prevalence of 1 to 5 stage of CKD was 8.61%, 5.10%, 3.03%, 0.48% and 0.16% respectively. In the acute phase of asthma, prevalence of CKD (24.42%) was significantly higher than that in chronic duration and clinical remission period (x2=12.445, P=0.002) and the same significant differences were found in albuminuria and reduced eGFR (x2=19.619, P〈0.01 and X2=9.305, P=0.010). Conclusion The bronchial asthma patients have higher incidence of renal damage and should be estimated, especially in the acute phase.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2011年第2期87-90,共4页 Chinese Journal of Nephrology
关键词 支气管哮喘 肾疾病 流行病学 筛查 Bronchial asthma Kidney disease Epidemiology Screening
  • 相关文献

参考文献11

  • 1Levey AS,Eckardt KU,Tsukamoto Y,et al.Definition and classification of chronic kidney disease:a position statement from Kidney Disease:Improving Global Outcomes (KDIGO).Kidney Int,2005,67:2089-2100.
  • 2Omar AS.Qinghua predictive value of microalbum-minuria in medical ICU patients.Chest,2001,129:1984-1988.
  • 3刘东伟,刘章锁,胡晓舟,邢国兰,施学忠.郑州市城区成年人慢性肾脏病流行病学调查[J].中华肾脏病杂志,2008,24(9):603-608. 被引量:41
  • 4张路霞,左力,徐国宾,王芳,王淑玉,王梅,吕继成,张军茹,刘力生,王海燕.北京市石景山地区中老年人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2006,22(2):67-71. 被引量:370
  • 5陈崴,王辉,董秀清,何惠娟,刘庆华,骆宁,谭嘉庆,林建雄,聂静,毛海萍,陈维清,余学清.广州市城区普通人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2007,23(3):147-151. 被引量:172
  • 6郭兰中,张路霞,王晓刚,张萍,赵巧萍,王芳,王海燕.浙江省某乡村慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2007,23(3):152-156. 被引量:65
  • 7Levey AS,Andreoli SP,DuBose T,et al.Chronic kidney disease:Common,harmful,and treatable-World Kidney Day 2007.J Am Soc Nephrol,2007,18:374-378.
  • 8Fixman ED,Stewart A,Martin JG.Basic mechanisms of development of airway structural changes in asthma.Eur Respir J,2007,292:379-389.
  • 9Fukuda N,Tahira Y,Matsuda H,et al.Transforming growth factor-beta as a treatment target in renal diseases.J Nephrol,2009,22:708-715.
  • 10García-Sánchez O,López-Hemández FJ,López-Novoa JM.An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease.Kidney Int,2010,77:950-955.

二级参考文献45

共引文献465

同被引文献35

  • 1何薇,宋康,陈芳.肺功能在诊断支气管哮喘合并慢性阻塞性肺疾病中的应用[J].中华哮喘杂志(电子版),2013,7(4):30-33. 被引量:18
  • 2张路霞,左力,徐国宾,王芳,王淑玉,王梅,吕继成,张军茹,刘力生,王海燕.北京市石景山地区中老年人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2006,22(2):67-71. 被引量:370
  • 3陈崴,王辉,董秀清,何惠娟,刘庆华,骆宁,谭嘉庆,林建雄,聂静,毛海萍,陈维清,余学清.广州市城区普通人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2007,23(3):147-151. 被引量:172
  • 4郭兰中,张路霞,王晓刚,张萍,赵巧萍,王芳,王海燕.浙江省某乡村慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2007,23(3):152-156. 被引量:65
  • 5Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: Improving Global Outcomes (KDIGO). Kidney Int, 2005, 67: 2089-2100.
  • 6Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med, 2003, 139: 137-147.
  • 7Knevel R, Schoels M, Huizinga TW, et al. Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis, 2010, 69: 987-994.
  • 8Li PK, Kwan BC, Leung CB, et al. Prevalence of silent kidney disease in Hong Kong: the screening for Hong Kong asymptomatic renal population and evaluation (SHARE) program. Kidney Int Suppl, 2005, 94: $36-$40.
  • 9Brown WW, Peters RM, Ohmit SE, et al. Early detection of kidney disease in community settings:the kidney early evaluation program (KEEP). Am J Kidney Dis, 2003, 42: 22-35.
  • 10Dieppe PA, Doyle DV, Burry HC, et al. Renal disease in rheumatoid arthritis. Br Med J, 1976, 1: 611-612.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部